Home/Filings/4/0000929638-23-003341
4//SEC Filing

BRYCE RICHARD PAUL 4

Accession 0000929638-23-003341

CIK 0001980845other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:55 PM ET

Size

5.0 KB

Accession

0000929638-23-003341

Insider Transaction Report

Form 4
Period: 2023-11-30
BRYCE RICHARD PAUL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-11-30+153,000153,000 total
    Exercise: $7.66Exp: 2033-11-30Common Shares (153,000 underlying)
Footnotes (1)
  • [F1]This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.

Documents

1 file

Issuer

enGene Holdings Inc.

CIK 0001980845

Entity typeother

Related Parties

1
  • filerCIK 0001553037

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:55 PM ET
Size
5.0 KB